🚨 New UNLOCK LC Consortium paper finds circulating nucleocapsid protein in Long COVID Patients AND Healthy Controls 👉Researchers found circulating nucleocapsid protein in 10/39 Long COVID patients, and 6/21 healthy controls. #longcovid #medsky #pedsky 1/ www.medrxiv.org/content/10.1...

Today’s HHIS Long COVID Roundtable was absolutely incredible! It was amazing to see Long COVID being discussed at the highest levels of government. Watch the full Roundtale here: x.com/longcovidlab... In this post, we'll go over some important takeways: 1/

I wrote how Long COVID isn’t a single problem to solve with a single pill Like HIV, TB, cancer and acute COVID, it demands combination therapies that tackle many layers at once It’s time to stop chasing silver bullets and start mixing the cocktail thesicktimes.org/2025/09/12/s...

The NIH met this week to launch Recover TLC- the next phase of its Long COVID research. Treatments for the next round of trials include: 👉 glucagon-like peptide-1 receptor agonists (GLP-1) 👉 stellate ganglion blocks 👉 low-dose naltrexone 👉 ⬆️ funding for an existing trial on baricitinib 1/

🚨The 3rd International Long COVID Conference is coming up in November! Check it out - details here! 👇 academicmedicaleducation.com/programs/3rd...

New #LongCOVID case study out! In this study, subjects were given a new drug called IMC-2, which is a combination of the herpesvirus antiviral drug valcyclovir and celexoxib, an anti-inflammatory which is believed to also have antiviral properties. 1/

💡Big news from Long COVID Labs! Our new Patient Grant Fund will provide up to $100,000 in funding to help patients access #LongCOVID treatments. We’re currently spreading the word to doctors and clinics, and want to make sure we don’t leave anyone out! Who do you recommend? Comment or DM us! 🙏

📢 How Can Real-World Evidence Be Used to Expedite Long COVID Treatments? Traditional research moves slowly, but Long COVID patients can't wait any longer. Learn how LONG COVID LABS is charting a new path to bring new treatments closer, faster! 👇 www.longcovidlabs.org/post/how-can...

LONG COVID LABS is excited to announce that we’ve awarded funds for a Long COVID patient to receive a combination treatment of Pemgarda monoclonal antibodies and Paxlovid! 1/

LONG COVID LABS governance proposals 004 and 005 are now live! As our momentum increases and we prepare for the next TGE vote, we’re putting forward 2 new governance proposals to help accelerate our progress and long-term value. Voting is live through 12 pm PT! discord.gg/wzDqF5xd See you there!

📢 Calling All #LongCOVID Patients! LONG COVID LABS is creating tools to make symptom tracking more useful, personalized, and patient-friendly. 📝 Take our quick survey to share your preferences: Your feedback will help shape the responsive tools we’re building! blocksurvey.io/symptom-trac...

🚨 So interesting! Can avoiding viral infections positively affect autoimmune diseases?

So interesting! Unfortunately, SARS-CoV-2 virus not the only virus that can persist after acute infection. In this recent study, the Morrison Lab at the University of Colorado found that Chikunguya virus persists in joint associated macrophages, leading to chronic disease. 1/ bit.ly/4mBOzwh

What if we could cure #LongCOVID? Our founder Rohan Dixit recovered from Long COVID through his own n=1 experiments. Now, his journey inspires him to help others.✨ More on the LONG COVID LABS mission here! 👇

WHAT WE’RE UP TO THIS WEEK: Hey everyone! We’ve been having a very busy summer working behind the scenes to get our Patient Registry up and running. We know so many of you are curious to know more about what we’re working on! Here’s what’s on deck for this week: 1/

Wow… this is fascinating! 🧐 Gut microbiome changes predicted Long COVID & MECFS with 90% accuracy?!

Hi everyone! Big heads up if you haven’t heard– Last week, we announced the launch of our Long COVID Patient Grant Fund.✨ 👉 To apply: longcovidlabs.org/post/patient... 👉 If you know someone with Long COVID, please share this grant application with them! We look forward to hearing from you! ✨

LONG COVID LABS is excited to announce our recent $22,000 Grant to Dr. Michael Peluso at UCSF. We'll be supporting Dr. Peluso's efforts to further study a blood test for SARS-CoV-2 spike Protein - an important potential measure of viral persistence in Long COVID! Read more here: 👇

🚨 Great interview with Dr. Michael Peluso from Cort Johnson of Health Rising Dr. Peluso explains why he’s “excited every day” about the future of Long COVID research 🙏 1/ www.healthrising.org/blog/2025/07...

📣LONG COVID LABS is pleased to announce the launch of our very first Patient Grant Fund! Through this initial fund, we're allocating $100,000 across multiple clinics to help patients afford the treatments they need. 1/

Our mission at Long COVID Labs is to accelerate evidence generation by capturing real-world #LongCOVID patient experiences, structuring them into a shared treatment registry, and funding patient access to promising therapies. 1/

Important article from @washingtonpost.com 👉Are our mainstream institutions failing to learn from the COVID pandemic? “The reality is that pandemics are going to hit. They’re going to hit again,” said @zalaly.bsky.social “It’s not a matter of if. It is a matter of when.” 1/

✨ July 2025 Updates from the Lab:✨ Today, we're announcing two major updates as part of our ongoing mission to accelerate a cure for Long COVID. 1/

🚨 Announcing that our current governance proposal LCL DP-3 has passed informal governance and moves to formal governance. Voting is now live on Snapshot through Sunday Jun 22nd at 2pm PT. LONG COVID LABS token holders, head here to cast your vote!👇 snapshot.box#/s:longcovid...

We're so grateful for the volunteers who contributed healthy control blood samples for the Long COVID biomarker that we are evaluating.🙏 Their contributions help advance real-world research — and each donor will receive a $COVID token airdrop as a reward! ✨ #LongCOVID #DeSci #Biomarkers

Announcing the new LONG COVID LABS Discord server! We’re excited to share our new Discord! We’ve heard your suggestions and want to create a more dynamic space to engage the community. ✨ 1/

We’re investigating possible biomarkers for SARS-CoV-2 viral persistence! ✨ Here’s our founder Rohan having his blood drawn by a mobile phlebotomist, as we run our biomarkers through a trial run. 🩸 1/

Wow... this would be REALLY cool if we could halt Alzheimer's! So much is to be learned from studying the role of chronic infections (like Long COVID) 🦠

Super cool to watch as the intricacies of the immune system come to light!

Exciting research from UVA Health into Long COVID lung injury: ✨ "By uncovering distinct immune patterns in patients…. we can better understand the immune drivers of lung injury and how these patterns may reflect different stages of the same disease process.... 1/

The hidden challenges of Long Covid are a growing danger, because the number of sufferers keeps increasing fast by millions.

@bioprotocol.bsky.social founder Paul Kolhaas giving a shoutout to LC Labs today at DeSci Berlin. Thanks Paul for raising awareness about our mission to find a cure for 100 million patients worldwide! 🌎

Super excited to check out DeSci Berlin this week! 🎉 Our team members Rohan and Austin are meeting with pioneers in the DAO and Web3 space to explore how new models of funding can speed up the pace of scientific research. 🙏 Can’t wait to see you all there!

PATIENT #1 - 1 MONTH UPDATE One month ago, Patient #1 in our case studies received a dose of Pemgarda monoclonal antibodies through his doctor, under the EUA. He combined this with 10 days of Paxlovid, with the goal of clearing persistent SARS-CoV-2 virus… 1/

Important topic 🚨 #longcovid

Really interesting take on the parallels between the climate crisis and the COVID-19 pandemic - we need solutions for both, NOW!

Every day we get closer to understanding the mechanisms of Long COVID🙏🙌

📣 Update on Patient #1 in Our Case Study Six days ago, the first patient in our case series received a combo treatment of Pemgarda monoclonal antibodies and Paxlovid, under the care of his physician. We know many of you are curious as to how he’s doing - here’s his update: #longcovid 🛟 1/

UPDATE: Patient #1 in our Pemgarda & Paxlovid Case Study Last Friday, we kicked off our initial Long COVID Labs-sponsored case study. Our very first patient received treatment with our physician partners. ✨ 1/

It’s here! We’re gearing up as the first LC Labs-supported case studies launch this week. The clinicians we’re collaborating with are prescribing a combination treatment of Pemgarda monoclonal antibodies and Paxlovid. ✨ 1/

📣 It’s happening. Patient #1 in our upcoming case study got his pre-treatment labs done this week!      We sent a mobile phlebotomist to his home to collect the sample.  We know how difficult it can be for very severe home- and bedbound patients to make it to a medical facility.  #longcovid 1/

I’m at the point with Long COVID where I’d rather start the treatments heading into trials, even in combination. I’ve done the research, the safety data exists, and waiting years isn’t realistic. It’s time doctors caught up too.

Every day since March 14, 2020 I have felt sick in one way or another. Every Covidversary feels bittersweet. Better than I was 2 years ago but likely never the same person I was 5 years ago. Grieving today and hoping it’s not another 5 years til we have effective treatments. #LongCovid #MEcfs

✨Throwback in case you missed it: Our founder Rohan’s talk at ETH SF last month ✨✨ #longcovid

Hi everyone, Here’s our newest update! What we’ve been up to👇 CASE STUDIES ✅ Finalized clinic location for first case studies Our first patient is tentatively booked for the third week of April (a week from now!) They will receive a Pemgarda infusion while taking 10 days of Paxlovid. 1/

Really interesting to see that getting immunized years after contracting a virus can still help prevent complications later on

Any movement to create a better future + extend human lifespan MUST take into account the ongoing impacts of SARS-CoV-2. Our mainstream institutions may try to downplay it and pretend everything is fine - but when has that worked for any other issue? Great post from @laboflivedexp.bsky.social!

Writing an article about combination drugs from the patient / research / etc perspective. What should I all cover?

✨ Amazing words of hope from leading Long COVID + ME/CFS researcher @ngklimas:✨ “…The answers will come for you and they are coming right now and they're coming fast and furious…. We’re going to get this thing. We're going to figure it out.” #longcovid 🛟

This looks really cool!